Age 0 3 0 3 B-age
â‰¤ 4 5 4 5 O
30 6 8 6 8 B-upper_bound
years 9 14 9 14 I-upper_bound
at 15 17 15 17 O
time 18 22 18 22 O
of 23 25 23 25 O
initial 26 33 26 33 O
qualifying 34 44 34 44 O
solid 45 50 45 50 B-cancer
tumor 51 56 51 56 I-cancer
diagnosis 57 66 57 66 O

Ewing 0 5 67 72 B-cancer
- 5 6 72 73 I-cancer
like 6 10 73 77 I-cancer
sarcoma 11 18 78 85 I-cancer

Histologic 0 10 86 96 O
diagnosis 11 20 97 106 O
of 21 23 107 109 O
solid 24 29 110 115 B-cancer
malignancy 30 40 116 126 I-cancer

Infantile 0 9 127 136 B-cancer
fibrosarcoma 10 22 137 149 I-cancer
without 23 30 150 157 I-cancer
NTRK 31 35 158 162 I-cancer
fusion 36 42 163 169 I-cancer

Inflammatory 0 12 170 182 B-cancer
myofibroblastic 13 28 183 198 I-cancer
tumor 29 34 199 204 I-cancer
without 35 42 205 212 O
ALK 43 46 213 216 O
fusion 47 53 217 223 O

Lacks 0 5 224 229 O
definitive 6 16 230 240 O
diagnosis 17 26 241 250 O
or 27 29 251 253 O
classical 30 39 254 263 O
genomic 40 47 264 271 O
findings 48 56 272 280 O
after 57 62 281 286 O
histologic 63 73 287 297 O
review 74 80 298 304 O
and 81 84 305 308 O
standard 85 93 309 317 O
molecular 94 103 318 327 O
testing 104 111 328 335 O
( 112 113 336 337 O
rare 113 117 337 341 O
tumor 118 123 342 347 B-cancer
group 124 129 348 353 O
) 129 130 353 354 O

Newly 0 5 355 360 O
diagnosed 6 15 361 370 O
high 16 20 371 375 O
risk 21 25 376 380 O
disease 26 33 381 388 O
, 33 34 388 389 O
defined 35 42 390 397 O
as 43 45 398 400 O
having 46 52 401 407 O
an 53 55 408 410 O
expected 56 64 411 419 O
event 65 70 420 425 O
free 71 75 426 430 O
survival 76 84 431 439 O
of 85 87 440 442 O
< 88 89 443 444 O
50 90 92 445 447 B-upper_bound
% 92 93 447 448 I-upper_bound
at 94 96 449 451 O
2 97 98 452 453 O
years 99 104 454 459 O

No 0 2 460 462 O
Therapy 3 10 463 470 B-treatment
Planned 11 18 471 478 O

Patient 0 7 479 486 O
has 8 11 487 490 O
already 12 19 491 498 O
had 20 23 499 502 O
molecular 24 33 503 512 B-treatment
profiling 34 43 513 522 I-treatment

Patients 0 8 523 531 O
who 9 12 532 535 O
have 13 17 536 540 O
declined 18 26 541 549 O
further 27 34 550 557 O
anticancer 35 45 558 568 B-treatment
therapy 46 53 569 576 I-treatment

Patients 0 8 577 585 O
with 9 13 586 590 O
anticipated 14 25 591 602 O
life 26 30 603 607 B-clinical_variable
expectancy 31 41 608 618 I-clinical_variable
< 42 43 619 620 O
3 44 45 621 622 B-upper_bound
months 46 52 623 629 I-upper_bound

Recurrent 0 9 630 639 O
, 9 10 639 640 O
defined 11 18 641 648 O
as 19 21 649 651 O
tumor 22 27 652 657 B-cancer
progression 28 39 658 669 O
after 40 45 670 675 O
achieving 46 55 676 685 O
a 56 57 686 687 O
prior 58 63 688 693 O
partial 64 71 694 701 O
or 72 74 702 704 O
complete 75 83 705 713 O
remission 84 93 714 723 O

Refractory 0 10 724 734 O
, 10 11 734 735 O
defined 12 19 736 743 O
as 20 22 744 746 O
tumor 23 28 747 752 B-cancer
progression 29 40 753 764 O
after 41 46 765 770 O
initiation 47 57 771 781 O
of 58 60 782 784 O
standard 61 69 785 793 O
first 70 75 794 799 B-treatment
line 76 80 800 804 I-treatment
therapy 81 88 805 812 I-treatment
without 89 96 813 820 O
having 97 103 821 827 O
achieved 104 112 828 836 O
a 113 114 837 838 O
prior 115 120 839 844 O
partial 121 128 845 852 O
or 129 131 853 855 O
complete 132 140 856 864 O
remission 141 150 865 874 O
OR 151 153 875 877 O
Biopsy 154 160 878 884 O
proven 161 167 885 891 O
residual 168 176 892 900 O
disease 177 184 901 908 O
at 185 187 909 911 O
the 188 191 912 915 O
completion 192 202 916 926 O
of 203 205 927 929 O
planned 206 213 930 937 O
standard 214 222 938 946 O
initial 223 230 947 954 O
front 231 236 955 960 B-treatment
- 236 237 960 961 I-treatment
line 237 241 961 965 I-treatment
therapy 242 249 966 973 I-treatment

Sufficient 0 10 974 984 O
tumor 11 16 985 990 B-cancer
specimen 17 25 991 999 O
available 26 35 1000 1009 O
to 36 38 1010 1012 O
meet 39 43 1013 1017 O
the 44 47 1018 1021 O
minimum 48 55 1022 1029 O
requirements 56 68 1030 1042 O
for 69 72 1043 1046 O
profiling 73 82 1047 1056 O
from 83 87 1057 1061 O
diagnosis 88 97 1062 1071 O
or 98 100 1072 1074 O
progression 101 112 1075 1086 O
/ 113 114 1087 1088 O
recurrence 115 125 1089 1099 O

Surgery 0 7 1100 1107 B-treatment
/ 8 9 1108 1109 O
biopsy 10 16 1110 1116 B-treatment
planned 17 24 1117 1124 O
as 25 27 1125 1127 O
part 28 32 1128 1132 O
of 33 35 1133 1135 O
clinical 36 44 1136 1144 O
care 45 49 1145 1149 O
that 50 54 1150 1154 O
is 55 57 1155 1157 O
anticipated 58 69 1158 1169 O
to 70 72 1170 1172 O
yield 73 78 1173 1178 O
sufficient 79 89 1179 1189 O
material 90 98 1190 1198 O
to 99 101 1199 1201 O
meet 102 106 1202 1206 O
the 107 110 1207 1210 O
minimum 111 118 1211 1218 O
requirements 119 131 1219 1231 O
for 132 135 1232 1235 O
profiling 136 145 1236 1245 O

Undifferentiated 0 16 1246 1262 B-cancer
sarcoma 17 24 1263 1270 I-cancer

brain 0 5 1271 1276 B-cancer
tumors 6 12 1277 1283 I-cancer

lymphoma 0 8 1284 1292 B-cancer

patient 0 7 1293 1300 O
has 8 11 1301 1304 O
not 12 15 1305 1308 O
yet 16 19 1309 1312 O
started 20 27 1313 1320 O
matched 28 35 1321 1328 O
targeted 36 44 1329 1337 O
therapy 45 52 1338 1345 B-treatment
based 53 58 1346 1351 O
on 59 61 1352 1354 O
the 62 65 1355 1358 O
report 66 72 1359 1365 O

